Lytix Biopharma AS (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 8.60
-0.08 (-0.92%)
Jun 6, 2025, 4:25 PM CET
Lytix Biopharma AS Revenue
Lytix Biopharma AS had revenue of 608.00K NOK in the twelve months ending March 31, 2025, down -95.81% year-over-year. In the year 2024, Lytix Biopharma AS had annual revenue of 11.13M with 178.98% growth.
Revenue (ttm)
608.00K
Revenue Growth
-95.81%
P/S Ratio
965.55
Revenue / Employee
76.00K
Employees
8
Market Cap
587.05M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 545.88M |
| Photocure ASA | 532.69M |
| Vistin Pharma ASA | 440.66M |
| Omda AS | 442.14M |
| Gentian Diagnostics ASA | 158.07M |
| ArcticZymes Technologies ASA | 102.97M |
| Nykode Therapeutics AS | 87.09M |